All Clinical Trials
Below is a list of all clinical trials, conducted by several of our specialty service lines. You may filter the list of trials by clicking the "Department" dropdown menu and selecting the area that you want to view or that pertains to you.
Clicking "Learn More" may either take you to more information about our departments that conduct the research, or to the official clinicaltrials.gov page for more information about the trial.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease (ZENITH)
Study # NCT07181109 Date Opened: 09/22/2025 Closing Date: 09/30/2030 Principal Investigator: Paul Gurbel, M.D. Sponsor: Alnylam Pharmaceuticals • Status: Recruiting
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants with Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
Study # NCT06948435 Date Opened: 04/30/2025 Principal Investigator: Paul Gurbel, M.D. Sponsor: Eli Lilly and Company • Status: Active, not recruiting
